CLEARPOINT NEURO INC. - COMMON STOCK

ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023

25 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

24 May 2023 09:25:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference

18 May 2023 16:01:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports First Quarter 2023 Results

11 May 2023 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles

10 May 2023 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023

28 Apr 2023 16:42:12 By Nasdaq GlobeNewswire

ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism™ Neuro Laser Therapy System

20 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model

18 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil

13 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS

11 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform

28 Mar 2023 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results

01 Mar 2023 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2022 Revenue Results March 1, 2023

15 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue

11 Jan 2023 08:00:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden

12 Dec 2022 09:15:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Present at Upcoming Investor Conferences

09 Nov 2022 09:25:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Third Quarter 2022 Results

08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Third Quarter 2022 Results November 8, 2022

26 Oct 2022 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therapy System

23 Sep 2022 02:45:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer

20 Sep 2022 16:05:00 By Nasdaq GlobeNewswire